...
首页> 外文期刊>Parkinsonism & related disorders >Visual impairment in Parkinson's disease treated with amantadine: Case report and review of the literature.
【24h】

Visual impairment in Parkinson's disease treated with amantadine: Case report and review of the literature.

机译:金刚烷胺治疗帕金森氏病的视力障碍:病例报告和文献复习。

获取原文
获取原文并翻译 | 示例
           

摘要

A 61-year-old man with Parkinson's disease (PD) developed sudden-onset visual impairment after initiation of amantadine treatment. Ophthalmologic examination revealed corneal endothelial edema. Discontinuation of amantadine resulted in rapid improvement of visual acuity. A review of the literature indicated only a few reports of amantadine-associated corneal dysfunction in patients with neurological disorders as well as influenza syndrome, but none with PD. Amantadine-associated visual impairment in PD could be possibly overlooked, since PD mainly affects elderly people who often develop aging-related ocular changes. The present report alerts neurologists and physicians in general to the peculiar ophthalmologic side effect of amantadine.
机译:开始使用金刚烷胺治疗后,一名61岁的帕金森氏病(PD)患者出现了突然发作的视力障碍。眼科检查发现角膜内皮水肿。金刚烷胺的停用导致视敏度的快速提高。文献综述仅显示了神经系统疾病和流感综合症患者中与金刚烷胺相关的角膜功能障碍的报道,而PD患者则没有。与金刚烷胺相关的PD视觉障碍可能会被忽略,因为PD主要影响经常发展与衰老相关的眼球变化的老年人。本报告提醒神经科医生和医师一般注意金刚烷胺的特殊眼科副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号